Resource Library

Webinars

Streamlining Drug Development: high-concentration formulation development

To meet the growing demand for complex and high-concentration biologics, early insight into molecular properties has become essential in formulation development. Samsung Biologics offers a strategic approach combining predictive assessments and formulation optimization platforms. DEVELOPICK™ 3.0 enables early candidate evaluation using small protein quantities and enhanced in silico tools, while S-HiCon™ provides optimized high-concentration formulation conditions through a systematic screening workflow.


In this webinar, we explain how Samsung Biologics leverages these platforms to reduce development risk and accelerate formulation—supporting efficient, high-quality drug product development.


Key learning objectives:

  • Learn how DEVELOPICK™ 3.0 enables early risk assessment with minimal protein input and enhanced in silico insights
  • Understand how rapid hydrophobicity testing supports proactive formulation and process planning
  • Discover how the S-HiCon™ platform helps define optimal conditions for high-concentration formulations over 100 mg/mL


To meet the growing demand for complex and high-concentration biologics, early insight into molecular properties has become essential in formulation development. Samsung Biologics offers a strategic approach combining predictive assessments and formulation optimization platforms. DEVELOPICK™ 3.0 enables early candidate evaluation using small protein quantities and enhanced in silico tools, while S-HiCon™ provides optimized high-concentration formulation conditions through a systematic screening workflow.


In this webinar, we explain how Samsung Biologics leverages these platforms to reduce development risk and accelerate formulation—supporting efficient, high-quality drug product development.


Key learning objectives:

  • Learn how DEVELOPICK™ 3.0 enables early risk assessment with minimal protein input and enhanced in silico insights
  • Understand how rapid hydrophobicity testing supports proactive formulation and process planning
  • Discover how the S-HiCon™ platform helps define optimal conditions for high-concentration formulations over 100 mg/mL


SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION